The efficacy of an allosteric modulator of the alpha 7 nicotinic acetylcholine receptor in a murine model of stroke
IntroductionIschemic strokes contribute significantly to cardiovascular-related deaths in the U.S., with current interventions limited to thrombolytic agents. However, these agents present challenges such as a limited therapeutic window, incomplete reperfusion rates, risk of transformation, reperfus...
Saved in:
Main Authors: | Katherine Hernandez, Nathan Jones, Sterling B. Ortega |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2025.1525975/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage
by: Daniel Ullrich, et al.
Published: (2025-02-01) -
Formulation and characterization of CMPI nanoparticles for enhanced targeting of brain nicotinic receptors by positive allosteric modulator
by: Rahma Aly, et al.
Published: (2025-02-01) -
CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01) -
Risk of Stroke Associated with Temperature and PM2.5: Taiwan Stroke Registry-based Study
by: Fung-Chang Sung, et al.
Published: (2023-08-01) -
Use of wearable technology in cardiac monitoring after cryptogenic stroke or embolic stroke of undetermined source: a systematic review
by: Jamie SY Ho, et al.
Published: (2024-07-01)